Skip to main content

Table 4 Average weekly doses by frequency of administration, dialysis type and total patients (mITT population; N = 411)

From: Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study

 

Average weekly doses (IU/kg)

Population by

Weeks 12–24

Weeks 37–52

Frequency of administration

n (%)

Mean ± SD

Median (Range)

n (%)

Mean ± SD

Median (Range)

3× per week

158 (100.0)

103.5 ± 88.0

77.9 (13.3–804.0)

126 (79.8)

114.4 ± 130.7

90.5 (0.0–1293.6)

2× per week

150 (100.0)

76.9 ± 58.5

62.2 (11.5–417.5)

131 (87.3)

79.2 ± 68.6

62.01 (2.5–436.5)

1× per week

103 (100.0)

65.9 ± 57.8

48.8 (2.3–335.0)

88 (85.4)

80.9 ± 96.8

47.5 (0.0–622.6)

Dialysis type

      

Predialysis

32 (100.0)

87.7 ± 73.5

56.0 (19.1–335.0)

26 (81.2)

122.6 ± 133.3

73.2 (14.9–622.6)

Haemodialysis

288 (100.0)

82.3 ± 57.9

66.5 (2.3–396.0)

242 (84.0)

90.5 ± 102.6

69.0 (0.0–1293.6)

Peritoneal dialysis

91 (100.0)

89.8 ± 107.3

60.4 (12.2–804.0)

77 (84.6)

88.8 ± 92.4

61.9 (4.4–436.5)

Total

411 (100.0)

84.4 ± 72.7

64.8 (2.3–804.0)

345 (83.9)

92.5 ± 103.1

66.0 (0.0–1293.6)